KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Assets (2016 - 2025)

Merck (MRK) has disclosed Assets for 17 consecutive years, with $136.9 billion as the latest value for Q4 2025.

  • On a quarterly basis, Assets rose 16.87% to $136.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $136.9 billion, a 16.87% increase, with the full-year FY2025 number at $136.9 billion, up 16.87% from a year prior.
  • Assets was $136.9 billion for Q4 2025 at Merck, up from $117.5 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $136.9 billion in Q4 2025 to a low of $90.7 billion in Q2 2021.
  • A 5-year average of $108.2 billion and a median of $106.9 billion in 2022 define the central range for Assets.
  • Peak YoY movement for Assets: increased 18.09% in 2022, then dropped 2.45% in 2023.
  • Merck's Assets stood at $105.7 billion in 2021, then increased by 3.28% to $109.2 billion in 2022, then decreased by 2.28% to $106.7 billion in 2023, then increased by 9.78% to $117.1 billion in 2024, then increased by 16.87% to $136.9 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Assets are $136.9 billion (Q4 2025), $117.5 billion (Q2 2025), and $117.1 billion (Q4 2024).